NASDAQ: $ILMN Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 Illumina, Inc. today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company reported solid performance across its core sequencing segments, reflecting continued momentum in both clinical adoption and research applications globally. Fourth Quarter Financial…